
News|Articles|November 18, 2025
Understanding Anti-Drug Antibody Assessment: Early Discovery through Clinical Trials
Author(s)Prolytix
Learn the unique considerations for use of ADA assays in early development, pre-clinical and clinical settings, as well as how to generate high-quality methods at each stage to support successful development and regulatory approval of safe and effective biotherapeutic drugs.
Trending on Pharmaceutical Technology
1
What Jideytro's Approval Means for Drug Developers
2
Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data
3
PharmTech Weekly Roundup—July 24, 2026
4
Midyear 2026 Check-In: AI Investment Skipped Pharma's Costliest Operational Problem
5